Relationship of glycosaminoglycan and matrix changes to vascular smooth muscle cell phenotype modulation in rabbit arteries after acute injury

Journal of Vascular Surgery

Volumn 33, Issue 1, 2001, Pages 155-164

  Bingley, John A ^a   Hayward, Ian P ^a   Campbell, Gordon R ^a   Campbell, Julie H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; CAROTID ARTERY INJURY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNOCHEMISTRY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0035140084     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.109774     Document Type: Article

References (50)

1. Kinetics of cellular proliferation after arterial injury, I: Smooth muscle growth in the absence of endothelium
2. Smooth muscle phenotypic changes in arterial wall homeostasis: Implications for the pathogenesis of atherosclerosis
3. Balloon catheter injury to rabbit carotid artery, I: Changes in smooth muscle cell phenotype
4. Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: An electron-microscopic and stereological study
5. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
6. Culture techniques and their applications to studies of vascular smooth muscle
7. Arterial smooth muscle cells in vivo: Relationship between actin isoform expression and mitogenesis and their modulation by heparin
8. Myosin gene expression and cell phenotypes in vascular smooth muscle during development, in experimental models, and in vascular disease
9. Regulation of differentiation of vascular smooth muscle cells
10. Smooth muscle diversity: Implications for the question, what is a smooth muscle cell?
11. Phenotypic modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury
12. Cytodifferentiation and expression of α-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells: Correlation with cell density and proliferative state
13. Changes in three-dimensional architecture of microfilaments in cultured vascular smooth muscle cells during phenotypic modulation
14. Suppression by heparin of smooth muscle cell proliferation in injured arteries
15. Inhibition of rat arterial smooth muscle cell proliferation by heparin: II: In vitro studies
16. Inhibition of rat arterial smooth muscle cell proliferation by heparin
17. Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotype change in vitro and neointimal formation in vivo
18. Developmental changes in heparan sulfate expression: In situ detection with mAbs
19. Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using specific monoclonal antibody
20. Quantitation of cells and fibers in histological sections of arterial walls: Advantages of contour tracing on a digitizing plate
21. Endothelial cell recoverage and inimal hyperplasia after endothelium removal with or without smooth muscle cell necrosis in the rabbit carotid artery
22. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury
23. Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype
24. Proliferating arterial smooth muscle cells after balloon injury express TNF-a but not interleukin-1 or basic fibroblast growth factor
25. Electron microscopy of elastic arteries. The thoracic aorta of the rat
26. Is vascular smooth muscle cell proliferation beneficial?
27. A paradigm for restenosis based on cell biology: Clues for the development of new preventative therapies
28. Effect of extracellular matrix proteins on vascular smooth muscle cell phenotype
29. Changes in elastin-binding proteins during the phenotypic transition of rabbit arterial smooth muscle cells in primary culture
30. Cell biology of arterial proteoglycans
31. Proteoglycan synthesis by the neointimal smooth muscle cells cultured from rabbit aortic explants following de-endothelialisation
32. Matrix metalloproteinases can facilitate the heparanase-induced promotion of phenotypic change in vascular smooth muscle cells
33. Glycosaminoglycan synthesis by smooth muscle cells of differing phenotype and their response to endothelial cell-conditioned medium
34. Transient morphological and biochemical alterations of arterial proteoglycan during early wound healing
35. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth
36. Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis
37. Vascular smooth muscle cell phenotype influences glycosaminoglycan composition and growth effects of extracellular matrix
38. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells
39. Bovine aortic smooth muscle cells synthesize two functionally different proteoheparan sulphate species
40. Heparin inhibition of smooth muscle cell proliferation: A cellular site of action
41. Distribution of glycosaminoglycans in consecutive layers of rabbit aorta
42. Isolation of proteoglycan-hyaluronic acid complexes from bovine aorta
43. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissue
44. In situ ultrastructural characterisation of chondroitin sulfate proteoglycans in normal rabbit aorta
45. Comparison of small proteoglycans from skin fibroblasts and vascular smooth muscle cells
46. Mechanotransduction by vascular smooth muscle
47. Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro
48. Morphological alteration of cultured arterial smooth muscle cells by cyclic stretching
49. Structural integration of the arterial wall. I. Relationships and attachments of medial smooth muscle cells in normally distended and hyperdistended aortas
50. Impaired elastogenesis in Hurler disease. Dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly